Preparation and in vitro characterization of monoclonal antibody ranibizumab conjugated magnetic nanoparticles for ocular drug delivery
Author:
Affiliation:
1. Marmara University, Turkey
2. Yeditepe University, Turkey
3. İstanbul Technical University, Turkey
Publisher
FapUNIFESP (SciELO)
Link
http://www.scielo.br/pdf/bjps/v56/2175-9790-bjps-56-e18171.pdf
Reference47 articles.
1. Synthesis of the newly developed core-shell au/Fe3O4 magnato-plasmonic nanocomposite in cancer cells;Ahmed OS;Life Sci. J.,2014
2. Magnetic nanoparticles: preparation, physical properties, and applications in biomedicine;Akbarzadeh A;Nanoscale Research Letters,2012
3. Intravireal bevacizumab (Avastin) for neovascular age-related macular degeneration;Avery R. L.;Ophtalmology,2006
4. Antibody humanization using monovalent phage display;Baca M;Journal of Biological Chemistry,1997
5. Synthesis of Magnetite Nanoparticles, Colloid and Surface Chemistry: a laboratory guide for exploration of the nano world;Bucak S,2013
Cited by 8 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Environmental effects and interaction of nanoparticles on beneficial soil and aquatic microorganisms;Environmental Research;2023-11
2. Development of a Ranibizumab Biosimilar Using Bovine Milk-Derived Exosomes for the Inhibition of Corneal Neovascularization;Letters in Drug Design & Discovery;2023-09
3. Nanotechnology in age-related macular degeneration;Nanotechnology in Ophthalmology;2023
4. Recent achievements in nano-based technologies for ocular disease diagnosis and treatment, review and update;Journal of Nanobiotechnology;2022-08-02
5. Modulated approaches for strategic transportation of proteins and peptides via ocular route;Journal of Drug Delivery Science and Technology;2021-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3